Johnson Johnson Visn Company Profile
✉ Email this page to a colleague
What is the competitive landscape for JOHNSON JOHNSON VISN, and when can generic versions of JOHNSON JOHNSON VISN drugs launch?
JOHNSON JOHNSON VISN has one approved drug.
There are two US patents protecting JOHNSON JOHNSON VISN drugs.
There are forty-four patent family members on JOHNSON JOHNSON VISN drugs in fifteen countries.
Summary for Johnson Johnson Visn
| International Patents: | 44 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Johnson Johnson Visn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Johnson Johnson Visn | ACUVUE THERAVISION WITH KETOTIFEN | ketotifen fumarate | DRUG-ELUTING CONTACT LENS;OPHTHALMIC | 022388-001 | Feb 25, 2022 | DISCN | Yes | No | 9,474,746 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Johnson Johnson Visn | ACUVUE THERAVISION WITH KETOTIFEN | ketotifen fumarate | DRUG-ELUTING CONTACT LENS;OPHTHALMIC | 022388-001 | Feb 25, 2022 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Johnson Johnson Visn | ACUVUE THERAVISION WITH KETOTIFEN | ketotifen fumarate | DRUG-ELUTING CONTACT LENS;OPHTHALMIC | 022388-001 | Feb 25, 2022 | DISCN | Yes | No | 9,962,376 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
